Kang HJ, Arrieta AC, Dhooge C, Kelemen A, et al. Phase 2, open-label, noncomparative clinical trial evaluating safety and efficacy of posaconazole in pediatric patients with proven/probable invasive aspergillosis or possible invasive fungal disease. Antimicrob Agents Chemother 2026 Jan 27:e0130525. doi: 10.1128/aac.01305.
PMID: 41589852